13-Aug-2025
Download PDF
Vivanza Bioscience
The Board of Directors of the Company at its meeting held today i.e. Wednesday August 13 2025 at Registered Office of the Company has inter alia considered and approved the Un-audited Standalone and Consolidated Financial Results along with Limited Review Report of the Company for the Quarter ended on 30th June 2025.
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
